Back to LENZ
CITADEL ADVISORS LLC LENZ Position History
LENZ Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$894K
Q3 2026
Peak value
$2.1M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $689K |
| Q1 2026 | $717K |
| Q2 2026 | $617K |
| Q2 2026 | $2.1M |
| Q2 2026 | $618K |
| Q2 2026 | $617K |
| Q2 2026 | $2.1M |
| Q2 2026 | $618K |
| Q3 2026 | $80K |
| Q3 2026 | $527K |
| Q3 2026 | $286K |
| Q3 2026 | $894K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $894K | 232.8K | — | — |
| Q3 2026 | $286K | 74.5K | — | — |
| Q3 2026 | $527K | 137.3K | — | — |
| Q3 2026 | $80K | 20.8K | — | — |
| Q2 2026 | $618K | 108.8K | — | — |
| Q2 2026 | $2.1M | 363.2K | — | — |
| Q2 2026 | $617K | 108.6K | — | — |
| Q2 2026 | $618K | 108.8K | — | — |
| Q2 2026 | $2.1M | 363.2K | — | — |
| Q2 2026 | $617K | 108.6K | — | — |
| Q1 2026 | $717K | 78.4K | — | — |
| Q1 2026 | $689K | 75.3K | — | — |